METHOD OF TREATING Helicobacter pylori ASSOCIATED CHRONIC ULCEROUS DISEASE OF STOMACH AND DUODENUM

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, and is intended for treatment of Helicobacter pylori (HP) associated chronic ulcerous disease of stomach and duodenum. Carried out is drug therapy, which includes per-oral introduction of sub-citrate of bismuth, omeprazole, amoxicillin and furazolidone, immune-modulator of microbial origin and complex bifido and lacto bacteria. As immuno-modulator of microbial origin introduced is ribomunyl. Dose is 750 mg. During the first month 1 time per day in the morning on an empty stomach on the first 4 days of each week. In the following 2 months -the first 4 days of each month. Complex bifido and lacto bacteria (LB-complex) in dose 5 ml, during 25 days from the first day of antibacterial medication intake. Intake is before 30 minutes before a meal. Content of microbial bodies in 1 ml of complex is 10¹⁰-10¹².;EFFECT: method makes it possible to correct secondary immunodeficiency and reduce treatment terms.;3 cl, 2 dwg, 2 ex